Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CC chemokine receptor 5 and renal-transplant survival.
Fischereder M, Luckow B, Hocher B, Wüthrich RP, Rothenpieler U, Schneeberger H, Panzer U, Stahl RA, Hauser IA, Budde K, Neumayer H, Krämer BK, Land W, Schlöndorff D. Fischereder M, et al. Lancet. 2001 Jun 2;357(9270):1758-61. doi: 10.1016/s0140-6736(00)04898-4. Lancet. 2001. PMID: 11403814
The chemokine receptor 5 Delta32 mutation is associated with increased renal survival in patients with IgA nephropathy.
Panzer U, Schneider A, Steinmetz OM, Wenzel U, Barth P, Reinking R, Becker JU, Harendza S, Zahner G, Fischereder M, Krämer BK, Schlöndorff D, Ostendorf T, Floege J, Helmchen U, Stahl RA. Panzer U, et al. Among authors: fischereder m. Kidney Int. 2005 Jan;67(1):75-81. doi: 10.1111/j.1523-1755.2005.00057.x. Kidney Int. 2005. PMID: 15610230 Free article.
Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial.
Schnuelle P, Gottmann U, Hoeger S, Boesebeck D, Lauchart W, Weiss C, Fischereder M, Jauch KW, Heemann U, Zeier M, Hugo C, Pisarski P, Krämer BK, Lopau K, Rahmel A, Benck U, Birck R, Yard BA. Schnuelle P, et al. Among authors: fischereder m. JAMA. 2009 Sep 9;302(10):1067-75. doi: 10.1001/jama.2009.1310. JAMA. 2009. PMID: 19738091 Clinical Trial.
Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trial.
Guba M, Pratschke J, Hugo C, Krämer BK, Nohr-Westphal C, Brockmann J, Andrassy J, Reinke P, Pressmar K, Hakenberg O, Fischereder M, Pascher A, Illner WD, Banas B, Jauch KW; SMART-Study Group. Guba M, et al. Among authors: fischereder m. Transplantation. 2010 Jul 27;90(2):175-83. doi: 10.1097/TP.0b013e3181e11798. Transplantation. 2010. PMID: 20463641 Clinical Trial.
Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36months after transplantation.
Guba M, Pratschke J, Hugo C, Krämer BK, Pascher A, Pressmar K, Hakenberg O, Fischereder M, Brockmann J, Andrassy J, Banas B, Jauch KW; SMART-Study Group. Guba M, et al. Among authors: fischereder m. Transpl Int. 2012 Apr;25(4):416-23. doi: 10.1111/j.1432-2277.2012.01432.x. Epub 2012 Feb 10. Transpl Int. 2012. PMID: 22320241 Free article.
165 results